Why isn't Lilly hyping Reta?

[DownWithTheSickness]

Has anyone else noticed that Lilly hasn't been promoting retatrutide in their recent press releases about upcoming medications?

 

[Tale_Teller]

They are probably too busy taking down social media accounts that even whisper the name 'retatrutide' haha!

 

[plot-twist]

I've heard whispers that they might brand it as either Retzoundi or Retkouro.

 

[Jamie09]

They're likely just focused on maximizing profits from their existing products right now.

 

[PeptidePro]

My guess is they're ramping up production to prevent shortages at launch and avoid the whole compounding situation like what happened with tirzepatide.

 

[Tale_Teller]

Based on all the lawsuits, it seems like they definitely don't want compounding to be an option.

 

[PurePal]

I think there's really no need to. The Phase III results will speak for themselves when they come out next spring.

 

[plot-twist]

I thought I read somewhere that we might see some Phase III data later this year.

 

[Compound_Goals]

That CEO pronounces it so strangely.

 

[Fit_Mom]

And honestly, I'm glad they aren't pushing it too hard. It benefits us in the long run, I think.

 

[Tale_Teller]

While I'm not a fan of censorship, I actually agree with Fit_Mom!!

 

[DownWithTheSickness]

Can either of you explain why you feel that way?

 

[Tale_Teller]

It's safer for them to be conservative with their statements until after FDA approval. Any overly positive claims now could temporarily inflate the stock price, only to cause a drop if the drug doesn't quite live up to the initial hype.

 

[plot-twist]

Social media buzz revealing the grey market attracts too much attention. We benefit from staying somewhat under the radar. These communities need a delicate balance: assisting those who need it without becoming a target for big money.

 

[Tale_Teller]

这就是为什么我们只用普通话发帖。
Zhè jiùshì wèishéme wǒmen zhǐ yòng pǔtōnghuà fātiē.

 

[DownWithTheSickness]

They heavily promote the oral version in company filings. They mention tons of other drugs in their pipeline, but not retatrutide. I've been an investor for a while and I'm just puzzled why they aren't talking about it more.

 

[Jamie09]

It's because they want people to start on tirzepatide now instead of waiting for reta, obviously.

 

[PeptidePro]

Most likely because it's readily available on the grey market.

 

[PeptidePro]

Is it Ruh-tat-tru-tide? I've been saying ret-ta-tru-tide...

 

[PurePal]

I've been saying Reht a TRU' Tied.